Prognostic impact of a history of cancer and atrial fibrillation in antithrombotic therapy for chronic heart failure.
Kotaro NochiokaSatoshi YasudaYasuhiko SakataTakashi ShirotoHideka HayashiJun TakahashiHiroyuki TakahamaSatoshi MiyataHiroaki ShimokawaPublished in: ESC heart failure (2022)
The CHF patients with history of cancer and AF had higher risk for stroke, systemic thrombosis, and major bleeding, especially in the elderly and those with IHD, but considerable number of the patients did not receive anticoagulant therapy, indicating the need for better optimal anticoagulation strategy.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- papillary thyroid
- left atrial appendage
- ejection fraction
- direct oral anticoagulants
- heart failure
- end stage renal disease
- squamous cell
- percutaneous coronary intervention
- newly diagnosed
- chronic kidney disease
- childhood cancer
- stem cells
- pulmonary embolism
- peritoneal dialysis
- venous thromboembolism
- coronary artery disease
- middle aged
- acute coronary syndrome
- community dwelling